Associated Papers
Congenital primary hyperparathyroidism.
Marini F et al.
Best Practice & Research. Clinical Endocrinology & Metabolism, 2025
Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant.
Tramontana TF et al.
Jco Precision Oncology, 2020
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.
Jia L et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2019
30980040 (PubMed )
Supplement: NIHMS1523944-supplement-1.xlsx › Sheet1
Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma.
Jafri M et al.
Cancer Discovery, 2015
MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
Georgitsi M
Best Practice & Research. Clinical Endocrinology & Metabolism, 2010
Familial isolated pituitary adenoma: evidence for genetic heterogeneity.
Toledo RA et al.
Frontiers of Hormone Research, 2010
Select a paper to view details